Jefferies Financial Group Forecasts Strong Price Appreciation for Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) had its price target upped by research analysts at Jefferies Financial Group from $230.00 to $260.00 in a note issued to investors on Tuesday, Benzinga reports. The firm currently has a “hold” rating on the biopharmaceutical company’s stock. Jefferies Financial Group’s price objective indicates a potential downside of […]
8 Sep 15:42 · The Markets Daily